v2.4.0.8
Condensed Consolidated Shareholders Equity (Unaudited) (USD $)
Common Stock
Preferred Stock
Deferred Stock Issuances
Additional Paid-In Capital
Accumulated Deficit During Development Stage
Total
Beginning balance at Dec. 31, 2012 $ 11,408 $ 0 $ (146) $ 45,886,596 $ (46,233,234) $ (335,376)
Beginning balance (in shares) at Dec. 31, 2012 11,408,274 0        
Non-voting preferred stock issued in February 2013 private placement at $0.70 per share, net (in shares)   761,429        
Non-voting preferred stock issued in February 2013 private placement at $0.70 per share, net   761   506,372   507,133
Conversion of Series A non-voting preferred stock to common stock (in shares) 474,105 (474,105)        
Conversion of Series A non-voting preferred stock to common stock 474 (474)       0
Deemed dividend related to beneficial conversion feature of Series A non-voting preferred stock       309,944 (309,944) 0
Repurchase of outstanding warrants       (33,000)   (33,000)
Stock-based compensation       431,849   431,849
Warrants issued in connection with license agreement       76,574   76,574
Stock issued in connection with senior convertible note conversion at $0.35 per share, Share 1,305,716          
Stock issued in connection with senior convertible note conversion at $0.35 per share, Amount 1,306     455,694   457,000
Stock issued in connection with warrants exercised, Shares 330,091          
Stock issued in connection with warrants exercised, Amount 330     59,670   60,000
Net loss         (3,197,923) (3,197,923)
Ending balance at Jun. 30, 2013 $ 13,518 $ 287 $ (146) $ 47,693,699 $ (49,741,101) $ (2,033,743)
Ending balance (in shares) at Jun. 30, 2013 13,518,186 287,324